A study designed to assess the usefulness of different criteria for monitoring status in RA unearthed the discovery that only one patient in ten appears to reach stable remission. How can this be true? It also identified the one factor that contributed most to this disappointing record.
The FDA Advisory Committee responsible for arthritis drugs is considering recent evidence that shows naproxen not to be associated with increased cardiovascular risk, unlike other painkillers in its class. Their recommendations may lead to suspension of a comparative clinical trial and to label changes.
Only about 10% of rheumatoid arthritis patients reach remission after a year on TNF-alpha inhibitors. Is this a problem with the regimen, the definition of remission, or the focus of the treatment target?
It's exciting to learn that injections of stem cells can improve recovery after arthroscopic meniscectomy. Or is it? A Harvard orthopedic surgeon who has studied the procedure raises a fundamental question about the concept.
How should rheumatologists respond to demands for medical marijuana, either from legislatures or directly from patients? Here from a knowledgeable source are 8 reasons (and more) why the medical and scientific evidence weighs heavily against it, especially in rheumatology.
(VIDEO) The shoulder is a simple joint without much space for injections. But with careful palpation and a test with a local anesthetic, you can assure correct placement of a steroid to relieve pain and inflammation.
(AUDIO) A new paradigm in pain research provides simple ways to identify patients with disorders like arthritis or lupus who won't respond to standard treatments. Pain expert Daniel Clauw MD gives the details in this podcast.
(AUDIO) Guidelines recommend some integrative approaches for low back pain, particularly spinal manipulation and massage. Here Dr. Wolf Mehling of University of California-San Francisco describes the options and the outcomes.